NP90726m Vedolizumab (Entyvio®)
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)contractFind a Tender ↗Ref ocds-h6vhtk-06bcbe32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
01 Jul 2026
Other contracts from The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)· 0
Most recent notices published by the same contracting authority.
No related contracts found.
Other contracts awarded to Takeda UK Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NP90726m Vedolizumab (Entyvio®) | contract | — | 25 Jun 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 22 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| Leuprorelin (Prostap®) | contract | — | 02 Dec 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |
| NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro) | contract | — | 02 May 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 | contract | — | 22 Apr 2025 |
| NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro) | contract | — | 04 Apr 2025 |